R. C. Kessler, P. Berglund, O. Demler, J. R. Merikangas, K. R. Walters et al., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication, Arch Gen Psychiatry, vol.62, pp.593-602, 2005.

W. W. Eaton, H. Shao, G. Nestadt, H. B. Lee, B. H. Lee et al., Populationbased study of first onset and chronicity in major depressive disorder, Arch Gen Psychiatry, vol.65, pp.513-533, 2008.

W. W. Ishak, J. Mirocha, D. James, G. Tobia, J. Vilhauer et al., Quality of life in major depressive disorder before/after multiple steps of treatment and oneyear follow-up, Acta Psychiatr Scand, vol.131, pp.51-60, 2015.

J. Lépine and M. Briley, The increasing burden of depression, Neuropsychiatr Dis Treat, vol.7, pp.3-7, 2011.

J. F. Greden, The burden of disease for treatment-resistant depression, J Clin Psychiatry, pp.26-31, 2001.

L. R. Olsen, E. L. Mortensen, and P. Bech, Prevalence of major depression and stress indicators in the Danish general population, Acta Psychiatr Scand, vol.109, pp.96-103, 2004.

A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, vol.163, pp.1905-1922, 2006.

M. Fava and K. G. Davidson, Definition and epidemiology of treatment-resistant depression, Psychiatr Clin North Am, vol.19, pp.70283-70288, 1996.

G. S. Malhi, G. B. Parker, J. Crawford, K. Wilhelm, and P. B. Mitchell, Treatment-resistant depression: resistant to definition?, Acta Psychiatr Scand, vol.112, pp.302-311, 2005.

D. Bennabi, B. Aouizerate, W. El-hage, O. Doumy, F. Moliere et al., Risk factors for treatment resistance in unipolar depression: a systema tic review, J Affect Disord, vol.171, pp.137-178, 2015.

D. Souery, P. Oswald, I. Massat, U. Bailer, J. Bollen et al., Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study, J Clin Psychiatry, vol.68, pp.1062-70, 2007.

M. Balestri, R. Calati, D. Souery, A. Kautzky, S. Kasper et al., Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study, J Affect Disord, vol.189, pp.224-256, 2016.

R. Correa, H. Akiskal, W. Gilmer, A. A. Nierenberg, M. Trivedi et al., Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?, J Affect Disord, vol.127, pp.10-18, 2010.

M. Berk and S. Dodd, Bipolar II disorder: a review, Bipolar Disord, vol.7, pp.11-21, 2005.

L. L. Judd, H. S. Akiskal, P. J. Schettler, W. Coryell, J. Endicott et al., A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder, Arch Gen Psychiatry, vol.60, pp.261-270, 2003.

S. N. Ghaemi, K. J. Rosenquist, J. Y. Ko, C. F. Baldassano, N. J. Kontos et al., Antidepressant treatment in bipolar versus unipolar depression, Am J Psychiatry, vol.161, pp.163-168, 2004.

R. H. Perlis, R. Uher, M. Ostacher, J. F. Goldberg, M. H. Trivedi et al., Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder, Arch Gen Psychiatry, vol.68, pp.351-60, 2011.

W. El-hage, S. Leman, V. Camus, and C. Belzung, Mechanisms of antidepressant resistance, Front Pharmacol, vol.4, p.146, 2013.

A. J. Rush, H. C. Kraemer, H. A. Sackeim, M. Fava, M. H. Trivedi et al., Report by the ACNP Task Force on response and remission in major depressive disorder, Neuropsychopharmacology, vol.31, pp.1841-53, 2006.

E. S. Paykel, R. Ramana, Z. Cooper, H. Hayhurst, J. Kerr et al., Residual symptoms after partial remission: an important outcome in depression, Psychol Med, vol.25, pp.1171-80, 1995.

I. W. Miller, G. I. Keitner, A. F. Schatzberg, D. N. Klein, M. E. Thase et al., The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine, J Clin Psychiatry, vol.59, pp.608-627, 1998.

L. Van-londen, R. P. Molenaar, J. G. Goekoop, A. H. Zwinderman, and H. G. Rooijmans, Three-to 5-year prospective follow-up of outcome in major depression, Psychol Med, vol.28, pp.731-736, 1998.

C. M. Thomas and S. Morris, Cost of depression among adults in England in 2000, Br J Psychiatry, vol.183, pp.514-523, 2003.

, American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision), Am J Psychiatry, vol.157, pp.1-45, 2000.

R. W. Lam, D. Mcintosh, J. Wang, M. W. Enns, T. Kolivakis et al., Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care, Can J Psychiatry, vol.61, pp.510-533, 2016.

I. M. Anderson, I. N. Ferrier, R. C. Baldwin, P. J. Cowen, L. Howard et al., Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines, J Psychopharmacol, vol.22, pp.343-96, 2008.

D. Goldberg, The "NICE Guideline" on the treatment of depression, vol.15, pp.11-16, 2006.

M. Bauer, A. Pfennig, E. Severus, P. C. Whybrow, J. Angst et al., Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders, World J Biol Psychiatry, vol.14, pp.334-85, 2013.

L. Samalin, S. Guillaume, P. Courtet, M. Abbar, S. Lancrenon et al., Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?, Compr Psychiatry, vol.54, pp.309-329, 2013.

V. De-carlo, R. Calati, and A. Serretti, Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: a systematic review, Psychiatry Res, vol.240, pp.421-451, 2016.

C. Henry, B. Etain, F. Mathieu, A. Raust, J. Vibert et al., A French network of bipolar expert centres: a model to close the gap between evidence-based medicine and routine practice, J Affect Disord, vol.131, pp.358-63, 2011.

A. H. Miller and C. L. Raison, The role of inflammation in depression: from evolutionary imperative to modern treatment target, Nat Rev Immunol, vol.16, pp.22-34, 2016.

M. E. Thase and A. J. Rush, When at first you don't succeed: sequential strategies for antidepressant nonresponders, J Clin Psychiatry, vol.58, issue.13, pp.23-32, 1997.

A. Frances, H. A. Pincus, and M. B. First, American Psychiatric Association DSM-IV-TR. 4ème édition texte révisé ed, 2000.

S. A. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, Br J Psychiatry, vol.134, pp.382-391, 1979.

R. C. Young, J. T. Biggs, V. E. Ziegler, and D. A. Meyer, A rating scale for mania: reliability, validity and sensitivity, Br J Psychiatry, vol.133, pp.429-464, 1978.

M. F. Janssen, A. S. Pickard, D. Golicki, C. Gudex, M. Niewada et al., Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study, Qual Life Res, vol.22, pp.1717-1744, 2013.

A. R. Rosa, J. Sánchez-moreno, A. Martínez-aran, M. Salamero, C. Torrent et al., Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder, Clin Pract Epidemiol, vol.3, p.5, 2007.

B. D. Dufton and C. M. Siddique, Measures in the day hospital. I. The global assessment of functioning scale, Int J Partial Hosp, vol.8, pp.41-50, 1992.

M. A. Oquendo, E. Baca-garcia, A. Kartachov, V. Khait, C. E. Campbell et al., A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression, J Clin Psychiatry, vol.64, pp.825-858, 2003.

A. J. Rush, M. Fava, S. R. Wisniewski, P. W. Lavori, M. H. Trivedi et al., Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design, Control Clin Trials, vol.25, pp.119-161, 2004.

D. Misdrahi, H. Verdoux, P. Llorca, and F. Baylé,

. L'encephale, , vol.30, pp.409-419, 2004.

D. J. Buysse, C. F. Reynolds, T. H. Monk, S. R. Berman, and D. J. Kupfer, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research, Psychiatry Res, vol.28, pp.193-213, 1989.

M. W. Johns, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, vol.14, pp.540-545, 1991.

P. A. Smith, D. F. Brown, D. Milia, L. Wragg, and C. , The use of the Circadian Type Inventory as a measure of the circadian constructs of vigour and rigidity, Ergonomics, vol.36, pp.169-75, 1993.

R. W. Beck, J. B. Morris, and A. T. Beck, Cross-validation of the Suicidal Intent Scale, Psychol Rep, vol.34, pp.445-451, 1974.

E. S. Paykel, J. K. Myers, J. J. Lindenthal, and J. Tanner, Suicidal feelings in the general population: a prevalence study, Br J Psychiatry, vol.124, pp.460-469, 1974.

K. Posner, G. K. Brown, B. Stanley, D. A. Brent, K. V. Yershova et al., The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults, Am J Psychiatry, vol.168, pp.1266-77, 2011.

D. P. Bernstein, L. Fink, L. Handelsman, J. Foote, M. Lovejoy et al., Initial reliability and validity of a new retrospective measure of child abuse and neglect, Am J Psychiatry, vol.151, pp.1132-1138, 1994.

E. S. Paykel, Contribution of life events to causation of psychiatric illness, Psychol Med, vol.8, pp.245-53, 1978.

C. L. Craig, A. L. Marshall, M. Sjöström, A. E. Bauman, M. L. Booth et al., International physical activity questionnaire: 12-country reliability and validity, Med Sci Sports Exerc, vol.35, pp.1381-95, 2003.

R. W. Lam, E. E. Michalak, and L. N. Yatham, A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder, BMC Psychiatry, vol.9, p.78, 2009.

J. Beecham and M. Knapp, Costing psychiatric interventions, Measuring Mental Health Needs, 1999.

E. G. Altman, D. Hedeker, J. L. Peterson, and J. M. Davis, The Altman Self-Rating Mania Scale, Biol Psychiatry, vol.42, pp.948-55, 1997.

R. M. Hirschfeld, J. B. Williams, R. L. Spitzer, J. R. Calabrese, L. Flynn et al., Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire, Am J Psychiatry, vol.157, pp.1873-1878, 2000.

C. Henry, M. Bailara, K. Mathieu, F. Poinsot, R. Falissard et al., Construction and validation of a dimensional scale exploring mood disorders: MAThyS (multidimensional assessment of thymic states), BMC Psychiatry, vol.8, p.82, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00342746

P. Tyrer, R. T. Owen, and D. V. Cicchetti, The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale, J Neurol Neurosurg Psychiatry, vol.47, pp.970-975, 1984.

A. Lesur, D. Bonnet, E. Vicaut, and T. Lempérière, Tyrer's Brief Scale for anxiety used with outpatients

. L'encephale, , vol.15, pp.535-577, 1989.

L. R. Goldberg, An alternative "description of personality": the big-five factor structure, J Pers Soc Psychol, vol.59, pp.1216-1245, 1990.

E. B. Blanchard, J. Jones-alexander, T. C. Buckley, and C. A. Forneris, Psychometric properties of the PTSD Checklist (PCL), Behav Res Ther, vol.34, pp.669-73, 1996.

J. H. Patton, M. S. Stanford, and E. S. Barratt, Factor structure of the Barratt impulsiveness scale, J Clin Psychol, vol.51, pp.768-74, 1995.

T. Wongpakaran, W. Tinakon, N. Wongpakaran, and W. Nahathai, A comparison of reliability and construct validity between the original and revised versions of the Rosenberg Self-Esteem Scale, Psychiatry Investig, vol.9, pp.54-62, 2012.

K. M. Connor, J. R. Davidson, L. E. Churchill, A. Sherwood, E. Foa et al., A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report, Br J Psychiatry, vol.176, pp.1519-1549, 2000.

T. Guo, Y. Xiang, X. L. Hu, C. Chiu, H. Ungvari et al., Measurementbased care versus standard care for major depression: a randomized controlled trial with blind raters, Am J Psychiatry, vol.172, pp.1004-1017, 2015.

A. J. Rush, Isn't it about time to employ measurement-based care in practice?, Am J Psychiatry, vol.172, pp.934-940, 2015.

P. F. Sullivan, M. C. Neale, and K. S. Kendler, Genetic epidemiology of major depression: review and meta-analysis, Am J Psychiatry, vol.157, pp.1552-62, 2000.

S. Ripke, N. R. Wray, C. M. Lewis, S. P. Hamilton, and M. M. Weissman, A mega-analysis of genome-wide association studies for major depressive disorder, Mol Psychiatry, vol.18, pp.497-511, 2013.

D. E. Pankevich, B. M. Altevogt, J. Dunlop, F. H. Gage, and S. E. Hyman, Improving and accelerating drug development for nervous system disorders, Neuron, vol.84, pp.546-53, 2014.

M. Gili, M. Garcia-toro, M. Vives, S. Armengol, J. Garcia-campayo et al., Medical comorbidity in recurrent versus first-episode depressive patients, Acta Psychiatr Scand, vol.123, pp.220-227, 2011.

M. Gili, A. Comas, M. García-garcía, S. Monzón, A. Roca et al., Comorbidity between common mental disorders and chronic somatic diseases in primary care patients, Gen Hosp Psychiatry, vol.32, pp.240-245, 2010.

M. Roca, M. Gili, M. Garcia-garcia, J. Salva, M. Vives et al., Prevalence and comorbidity of common mental disorders in primary care, J Affect Disord, vol.119, pp.52-60, 2009.

A. Kleiboer, J. Smit, J. Bosmans, J. Ruwaard, G. Andersson et al., European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries, Trials, vol.17, p.387, 2016.